rs151293980
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001253852.3(AP4B1):c.175A>G(p.Thr59Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000103 in 1,614,100 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T59S) has been classified as Uncertain significance.
Frequency
Consequence
NM_001253852.3 missense
Scores
Clinical Significance
Conservation
Publications
- AP-4 deficiency syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hereditary spastic paraplegia 47Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- AP4-related intellectual disability and spastic paraplegiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| AP4B1 | NM_001253852.3 | c.175A>G | p.Thr59Ala | missense_variant | Exon 2 of 10 | ENST00000369569.6 | NP_001240781.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0000788  AC: 12AN: 152208Hom.:  0  Cov.: 33 show subpopulations 
GnomAD2 exomes  AF:  0.000103  AC: 26AN: 251494 AF XY:  0.0000809   show subpopulations 
GnomAD4 exome  AF:  0.000106  AC: 155AN: 1461892Hom.:  0  Cov.: 31 AF XY:  0.000121  AC XY: 88AN XY: 727248 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000788  AC: 12AN: 152208Hom.:  0  Cov.: 33 AF XY:  0.0000673  AC XY: 5AN XY: 74348 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 47    Uncertain:2 
- -
This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 59 of the AP4B1 protein (p.Thr59Ala). This variant is present in population databases (rs151293980, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with AP4B1-related conditions. ClinVar contains an entry for this variant (Variation ID: 472194). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt AP4B1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases    Uncertain:1 
The c.175A>G (p.T59A) alteration is located in exon 3 (coding exon 2) of the AP4B1 gene. This alteration results from a A to G substitution at nucleotide position 175, causing the threonine (T) at amino acid position 59 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided    Uncertain:1 
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 25552650, 27535533) -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at